Sorted By:

Relevance


More Than 50 Medicines and Vaccines in Development for HIV Infection, Treatment and Prevention

PhRMA  |  Press Release

The full “Medicines in Development for HIV/AIDS” report can be downloaded here.
https://www.phrma.org

List of 2015 Medicines in Development for Cancer

PhRMA  |  Report

The report outlines all medicines including their product name, sponsor, indication and development/phase.
https://www.phrma.org/report/list-of-2015-medicines-in-development-for-cancer

How Are Your Medicines Covered?

PhRMA  |  From PhRMA

Access Better Coverage is an educational resource designed to break down the basics of health insurance and help families find the best coverage available. Watch engaging videos, make sense of confusing insurance jargon, and get the l...
https://www.phrma.org/patients/how-are-your-medicines-covered

List of 2016 Medicines in Development for Mental Illnesses

PhRMA  |  Report

The attached report outlines the complete list of the 135 medicines in development for mental illnesses.
https://www.phrma.org/report/list-of-2016-medicines-in-development-for-mental-illnesses

Ask About Adherence: Discussion on medication adherence as national priority

PhRMA  |  Blog Post

Ask About Adherence is a blog series featuring discussions with experts and new medication adherence resources.
http://catalyst.phrma.org/ask-about-adherence-discussion-on-medication-adherence-as-national-priority

Medicines in Development for Autoimmune Disease Drug List

PhRMA  |  Report

View the full list of medicines currently in development to treat the 80+ autoimmune diseases that have been identified to-date. ...
https://www.phrma.org/report/medicines-in-development-for-autoimmune-disease-drug-list

Medicare Part D Pocket Card

PhRMA  |  Report

Medicare Part D, the outpatient prescription drug benefit, provides seniors and individuals with disabilities access to affordable prescription drug coverage. Part D allows beneficiaries to choose from a range of private plans that best meet their needs. Now, 90% of Medicare beneficiaries receive...
https://www.phrma.org/report/medicare-part-d-pocket-card

Achieving Optimal Value from Medicines

PhRMA  |  Report

This presentation explores the opportunities and barriers for better use of medicines, the clinical and economic benefits to medicine adherence, and how adherence to medicines affects high cost sharing....
https://www.phrma.org/report/achieving-optimal-value-from-medicines

Driving Innovation and Economic Growth for the 21st Century

PhRMA  |  Report

This report details the continuing rise of state policies and programs to attract, retain, and grow an innovative biopharmaceutical presence.
https://www.phrma.org

Poll respondents appreciate economic benefits of innovation and call for more protections

PhRMA  |  Blog Post

In fact, a report released earlier this year from the Global Intellectual Property Center, declared a robust innovation environment as “essential to the success of any 21st century economy.”
http://catalyst.phrma.org/poll-respondents-appreciate-economic-benefits-of-innovation-and-call-for-more-protections

Policy Solutions: Promoting Value-Driven Health Care

PhRMA  |  Report

Over the last half-century, new medicines, technologies and biopharmaceutical research have revolutionized health care and helped millions of patients live longer, healthier lives. Building on this progress, America now is on the cusp of a golden era of biopharmaceutical discovery and personalize...
https://www.phrma.org/report/policy-solutions-promoting-value-driven-health-care

America's Pharma Industry Supports Passage of Korea-U.S. Free Trade Agreement

PhRMA  |  Report

By reducing and eliminating both tariff and non-tariff barriers to trade between Korea and the United States, the agreement will play a key role in strengthening the U.S. economy and increasing American jobs and exports.
https://www.phrma.org/report/america-s-pharma-industry-supports-passage-of-korea-u-s-free-trade-agreement

A Decade of Innovation in Chronic Diseases

PhRMA  |  Report

Chronic diseases are one of the most complex and important health care challenges of our time. Seven out of ten deaths in the United States are due to chronic health conditions, and about half of all American adults have one or more of these conditions. Generally regarded as health condit...
https://www.phrma.org/report/a-decade-of-innovation-in-chronic-diseases

List of Medicines in Development for Diabetes

PhRMA  |  Report

View the full list of medicines currently in development for diabetes. ...
https://www.phrma.org/report/list-of-medicines-in-development-for-diabetes

How Competitive Biopharm Marketplaces Help Control Costs

PhRMA  |  Report

Too often conversations on the cost of medicines fail to acknowledge the competitive biopharmaceutical market that exists in the U.S., which helps to control costs while encouraging the development of innovative new therapies. Spending on retail prescription medicines has consistently acc...
https://www.phrma.org/report/how-a-competitive-biopharmaceutical-marketplace-helps-to-control-costs

2005 - 2015: A Decade of Innovation In Rare Diseases

PhRMA  |  Report

Unfortunately, rare diseases often are difficult to diagnose, and in many cases, few or no treatment options are available. Because of the rarity of each disease itself, however, much remains unknown about the underlying causes and the clinical course of many rare diseases. Even within a particul...
https://www.phrma.org/report/2005-2015-a-decade-of-innovation-in-rare-diseases

Medicines in Development for Vaccines Drug List

PhRMA  |  Report

Explore the vaccines in development by drug name, sponsor, indication and development phase. There are over 250 vaccines currently in development....
https://www.phrma.org/report/medicines-in-development-for-vaccines-drug-list

Milliman - 2016 Medicare Part D National Average Value Drivers

PhRMA  |  Report

The report outlines the results, key drivers, caveats and limitations.
https://www.phrma.org/report/milliman-2016-medicare-part-d-national-average-value-drivers

Read More About Medicines in Development for Neurological Disorders

PhRMA  |  Report

Related Content: 2015 Report: Medicines in Development for Neurological Disorders (PDF) Press Release: PhRMA and Epilepsy Foundation Report More Than 400 Medicines in Development to Treat Neurological Disorders
https://www.phrma.org/report/read-more-about-medicines-in-development-for-neurological-disorders

Innovation Spotlight: What is the Future of Health Care?

PhRMA  |  Video

The speakers also touched upon policy solutions to advance market-based reforms that promote competition and modernize the drug discovery and development process.
https://www.phrma.org

The Value of Innovation in Oncology - Recognizing Emerging Benefits Over Time Executive Summary

PhRMA  |  Report

A new white paper by Boston Healthcare Associates examines how innovative medicines are driving significant progress in the fight against cancer. Though initial approval by the U.S. Food and Drug Administration is a tremendous milestone, ongoing research and accumulation of knowledge reveals bene...
https://www.phrma.org/report/the-value-of-innovation-in-oncology-recognizing-emerging-benefits-over-time-executive-summary

Impact of deductibles in health plans

PhRMA  |  Blog Post

The report also suggests this trend could have a negative impact on health, since IMS found that patients with pharmacy deductibles have lower adherence to drug therapies and higher prescription abandonment rates than patients without pharmacy deductibles.
http://catalyst.phrma.org/impact-of-deductibles-in-health-plans

Prescription Drug Misuse, Abuse & Disposal

PhRMA  |  From PhRMA

PhRMA has several alliances with organizations working to prevent prescription drug abuse: The Partnership for Drug-Free Kids Medicine Abuse Project, which provides comprehensive resources for parents and caregivers, law enforcement officials, health care providers, educators and others so that everyone can take a stand and help end medicine abuse.
https://www.phrma.org/advocacy/safety/prescription-misuse-abuse

The 5 Essential Truths about Prescription Drug Spending

PhRMA  |  Report

Every day patients around the world are living healthier, more productive lives thanks to innovative medicines developed by biopharmaceutical companies. Retail prescription medicines have consistently accounted for just 10 percent of United States health care spending and federal actuaries projec...
https://www.phrma.org/report/the-five-essential-truths-about-prescription-drug-spending

PhRMA Kicks Off National Health Care Dialogue to Examine the New Era of Medicine

PhRMA  |  Press Release

For reporters interested in speaking with The Atlantic, please contact Sydney Simon at ssimon@theatlantic.com.
https://www.phrma.org/press-release/phrma-kicks-off-national-health-care-dialogue-to-examine-the-new-era-of-medicine

You have reviewed the first 275 results out of 1009. Each page contains 25 results. You're on page 11.

prev 7 8 9 10 11 12 next